Beks Hannah, Binder Marley J, Clayden Suzanne, Ludowyk Justin, Campbell David, Freeman Jessica, Collins Ian M, Underhill Craig, Buzza Mark, Barrett Michelle, Faisal Wasek, Swiatek Dayna, Ugalde Anna
Institute for Health Transformation, Centre for Quality and Patient Safety Research, Deakin University, Warrnambool, VIC, Australia.
Deakin Rural Health, School of Medicine, Deakin University, Warrnambool, VIC, Australia.
BMC Health Serv Res. 2025 Jul 1;25(1):831. doi: 10.1186/s12913-025-12990-5.
To undertake a qualitative evaluation of the implementation of the Penile and Testicular cancer multidisciplinary meeting (PEN-TEST MDM) model pilot including the acceptability, adoption, appropriateness, feasibility, and requirements for sustaining the model from the perspectives of key informants.
DESIGN, SETTING, PARTICIPANTS: A qualitative evaluation of the PEN-TEST MDM model six-month implementation pilot at Barwon Health (Victoria, Australia) (January to July 2024) was undertaken from July to September 2024. Qualitative data was obtained from semi-structured interviews undertaken with key informants, including working group members and end-users (referring and attending clinicians). Data was analysed abductively and reported, guided by Proctor’s implementation outcomes framework.
Key themes pertaining to implementation outcomes based on qualitative analysis.
Thirteen key informants were interviewed. Three key concepts were developed: (1) value for the clinician workforce: acceptability and adoption, (2) optimising patient care: appropriateness and feasibility, and (3) considerations for sustainability and scalability.
The PEN-TEST MDM model is a promising approach for reviewing patient cases with penile or testicular cancer. Findings support the importance of ongoing stakeholder engagement to shape the next iteration, and further investment to refine, sustain, and scale the model. Subject to this, scoping opportunities for scaling to other less common or rare cancers is warranted. The MDM model established has potential to be transformative in addressing inequitable access to specialist cancer care.
The online version contains supplementary material available at 10.1186/s12913-025-12990-5.
从关键信息提供者的角度，对阴茎癌和睾丸癌多学科会议（PEN-TEST MDM）模式试点的实施情况进行定性评估，包括该模式的可接受性、采用情况、适宜性、可行性以及维持该模式所需的条件。
设计、地点、参与者：于2024年7月至9月对澳大利亚维多利亚州巴旺健康中心（Barwon Health）为期6个月的PEN-TEST MDM模式实施试点进行了定性评估。定性数据来自与关键信息提供者（包括工作组成员和最终用户，即转诊和出诊的临床医生）进行的半结构化访谈。数据采用归纳法进行分析，并根据普罗克特的实施成果框架进行报告。
基于定性分析得出的与实施成果相关的关键主题。
共访谈了13名关键信息提供者。确定了三个关键概念：（1）对临床医生队伍的价值：可接受性和采用情况；（2）优化患者护理：适宜性和可行性；（3）可持续性和可扩展性的考量。
PEN-TEST MDM模式是一种审查阴茎癌或睾丸癌患者病例的有前景的方法。研究结果支持持续让利益相关者参与以塑造下一阶段模式的重要性，以及进一步投入以完善、维持和扩大该模式。在此前提下，有必要探讨将该模式扩展到其他不太常见或罕见癌症的机会。已建立的MDM模式在解决专科癌症护理获取不平等问题方面具有变革潜力。
在线版本包含可在10.1186/s12913-025-12990-5获取的补充材料。
